visible

Hero

<h1 class="ql-align-center">SCALE</h1> <h2 class="ql-align-center">BeyondBio</h2> <h2 class="ql-align-center">From Sturtup to Scale Up</h2><img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fhero-logos.png?alt=media&amp;token=333b91ad-04eb-4d7f-a792-3a909b83f869" alt="123123">

<h2>NAVIGATING THE PATH TO DEPLOYMENT AT SCALE</h2> BeyondBio SCALE connects healthcare needs to solutions at scale and at speed, through a unique 9-month program. Selected evidence-based startups get a seat at the table with an extraordinary, interdisciplinary team of global partners: Accenture, AWS, and Clalit Innovation, as well as AstraZeneca. Each sharing world-class insights, expertise, resources, and connections to accelerate your startup’s deployment at scale. Our vision: to dramatically improve patient care and healthcare systems around the world, by advancing cutting-edge science, technology, and innovation worldwide.

Ready

<h2>1. READY TO SCALE? LET'S TALK</h2> You’ve built a great, evidence-backed startup, with potential to make a real impact in the healthcare space. Now, BeyondBio SCALE can help you grow successfully and efficiently. To ensure mutual compatibility, we’ll first assess your solution and its ability to address key challenges in the following clinical focus areas: <ul><li>Respiratory and Immunology</li><li>Cardiovascular, Renal &amp; Metabolic Diseases</li><li>Oncology</li><li>Vaccines and Infections</li></ul> The most relevant and promising solutions will be accepted, and each participating company will receive support tailored to its own unique needs.

Identify

<h2>2. IDENTIFY A SCALABLE USE CASE WITH ECOSYSTEM PLAYERS</h2> Together with our program partners – AstraZeneca, Accenture, AWS and Clalit Health Services, we’ll identify a specific, scalable use case for your technology. We then engage ‘champions’ from our global organizations, matching you with relevant experts, resources and senior business leaders who can help propel your solution onto the global deployment stage.

Validate

<h2>3. VALIDATE YOUR SOLUTION TOWARDS IMPLEMENTATION</h2> At this stage we’ll help you create a detailed plan for scaling. Based on the use case, your solution will be analyzed from different angles including the commercial, clinical, regulatory, technology and business perspectives.&nbsp;We’ll&nbsp;stress-test, revise and iterate together, utilizing core competencies of the program partners as needed. Together, we’ll set a series of practical discussions with relevant stakeholders, aspiring to achieve maximum readiness for growth.

Start Scaling

<h2>4. START SCALING</h2> Now you’re ready to deploy your solution, implementing&nbsp;the right model and metrics for your use case. The pathways to deployment could range from a pilot abroad, to a validation study, a collaboration agreement, a product launch at scale, and more. BeyondBio is deeply committed to turbocharging innovation – and that means this process doesn’t end after the 9-month program.&nbsp;The foundations and connections we build together will continue to evolve into the future. So, are you ready to SCALE?

Learn More

KEY CHALLENGES

We’re seeking companies with innovative digital health solutions in the following clinical areas: a. Respiratory and Immunology - COPD, Severe Asthma, Lupus b. Cardiovascular, Renal and Metabolic disease - Heart Failure, CKD c. Oncology - Lung, Ovarian, Prostate, Breast, Hematologic or other cancer types d. Vaccines and Infectious diseases – COVID, Flu In addition, solutions should address at least one of the key challenges below: a. Early disease detection &amp; disease management - Reduce the burden on healthcare systems by identifying patients for earlier diagnosis and empower the wider population with knowledge and tools to better understand and manage their disease b. Multidisciplinary teams (MDT) support platforms &amp; tools - Improve knowledge sharing and collaboration between physicians across specialties and healthcare organizations to drive better and faster treatment decisions for patients c. Data insights, optimization &amp; management - Facilitate data collection, sharing and analysis to generate meaningful scientific and medical insights supporting delivery of care in a compliant and efficient way d. AI platforms supporting drug discovery &amp; development - Improving the probability of success, efficiency and timeline of the R&amp;D journey with the help of AI

WHAT YOU RECEIVE

Experts - Direct access to the industry leaders and partners’ networks, including global healthcare providers and payers, medical and regulatory experts and go-to-market specialists Planning - Tailored and customized plan for a 9-month program to prepare for the next stage of scaling your digital health solution Guidance - Receive consulting related to your value proposition, product/market fit and evaluation of clinical, technology, and business evidence Validation - Strategic engagements with partners and potential customers to build and validate a viable use case Deployment - Work directly with program partners to execute implementation pilots targeting scale Networking and exposure - Enjoy links to the global network of the program partners including health systems, providers, payors, tech companies and others. Gain exposure to your targeted audience

SELECTION CRITERIA

Companies will be selected to the program based on the following criteria: 1. Maturity - the Company should have a product in the market, sufficient clinical evidence in place and regulatory approvals in at least one key market (or plan to gain such approvals within 6-8 months). 2. Scalability - the Company should be able to demonstrate the ability to scale globally beyond Israel and work with a high volume of users. 3.&nbsp;Stability - the&nbsp;Company should be currently funded, with a strong team and business model, and infrastructure in place. 4.&nbsp;Israel - the&nbsp;Company should be registered in Israel or have an active local presence.

TIMELINE

Coming soon: Application dates for our 2024 BeyondBio SCALE cohort

OUR PARTNERS

<img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fastra.png?alt=media&amp;token=29d81f1c-61a7-44e3-967a-893457601fd6" alt="astra-logo"> AstraZeneca launched BeyondBio in 2019, with the first cohort of BeyondBio SCALE getting underway the following year, in collaboration with distinguished partners from across the ecosystem. Our current BeyondBio SCALE partners include: AstraZeneca Israel: <a href="https://www.astrazeneca.com/country-sites/israel.html" rel="noopener noreferrer" target="_blank" style="color: rgb(95, 2, 31);">astrazeneca.com/country-sites/israel</a> <img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Faccenture.png?alt=media&amp;token=c0204d4a-6c37-4405-b65b-bf0e3f1fb948" alt="null"> Accenture is a global professional services company with leading capabilities in digital, cloud and security. Combining unmatched experience and specialized skills across more than 40 industries, we offer Strategy and Consulting, Technology and Operations services and Accenture Song — all powered by the world’s largest network of Advanced Technology and Intelligent Operations centers. Our 699,000 people deliver on the promise of technology and human ingenuity every day, serving clients in more than 120 countries. We embrace the power of change to create value and shared success for our clients, people, shareholders, partners and communities. Accenture life sciences helps the World’s leading biopharma companies bring their vision to life – enabling them to improve outcomes by converging around the patient, connecting scientific expertise with unique insights into the patient experience. Our services span across the entire life sciences enterprise, from research laboratories, clinical trials, and regulatory services, to pharmacovigilance and patient services solutions. Delivered by biopharma and biotech experts, our services are powered by an integrated, intelligent technology solution – the Accenture INTIENT platform. Accenture Health harnesses the power of technology and human ingenuity to help clients improve access, experience, and outcomes in healthcare. With the help of our innovative, technology-enabled services, clients are delivering effective and personalized experiences that humanize healthcare for all. Visit us at&nbsp;<a href="https://www.accenture.com" rel="noopener noreferrer" target="_blank" style="color: rgb(95, 2, 31);">https://www.accenture.com</a> Find out more on Accenture Life Sciences&nbsp;here:&nbsp;<a href="https://www.accenture.com/us-en/industries/life-sciences-index" rel="noopener noreferrer" target="_blank" style="color: rgb(95, 2, 31);">https://www.accenture.com/us-en/industries/life-sciences-index</a> For more information on Accenture Health visit at&nbsp;<a href="https://www.accenture.com/ca-en/industries/health-index" rel="noopener noreferrer" target="_blank" style="color: rgb(95, 2, 31);">https://www.accenture.com/ca-en/industries/health-index</a> <img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Faws.png?alt=media&amp;token=30bff15e-8677-45a6-8598-57a29ef66129" alt="null"> AWS is the trusted technology partner to the global healthcare and life sciences industry. For over 14 years, Amazon Web Services has been the world’s most comprehensive and broadly adopted cloud platform. Trusted by thousands of healthcare and life sciences customers around the world—including the fastest-growing startups, the largest enterprises, and the leading government agencies. AWS offers secure and compliant solutions to keep protected health information (PHI) private enabling the highly regulated healthcare and life sciences industry to increase the pace of innovation, unlock the potential of data, improve clinical and operational efficiency, and personalize the healthcare journey, improving the healthcare experience and ultimately patient outcomes. <a href="https://aws.amazon.com/health/" rel="noopener noreferrer" target="_blank" style="color: rgb(95, 2, 31);">aws.amazon.com/health</a> <img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fclalit.png?alt=media&amp;token=ad38e0fe-2220-4c1e-9ce1-43e4054b5c00" alt="null"> Clalit, the largest and leading HMO in Israel, provides medical services to more than 52% of the Israeli population, with a wide range of medical services: outpatient clinics throughout the country, where there are women's health centers, pediatric health centers, and specialized medical centers. In addition, Clalit manages 14 public hospitals, and provides an additional set of services through subsidiary companies that include the network of dental clinics Clalit Smile, Clalit Aesthetics, Clalit Complementary Medicine, and 'Mor' Medical Institutes and Services. Clalit works to prevent disease and promote a healthy lifestyle through offering quality medical services, and advanced on-line services that provide the ability to receive medical services from anywhere, and at any time.

Participants

<h3>STARTUPS ON THEIR JOURNEY TO SCALE</h3>

<img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fc2i.png?alt=media&amp;token=30f62f98-cd84-4f1d-a7d7-5d57a8e06d1b" alt="null"> <h2>A blood test that can identify recurrent cancer</h2><h4> </h4>

IBEX

<img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fibex.png?alt=media&amp;token=9b2aeeb4-cbe9-49c0-ad17-9050ec834af7"><h2>Ibex Medical Analytics launches AI-powered breast cancer biomarker scoring platform</h2>

Cordio

<img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fcordio.png?alt=media&amp;token=5efde054-9bdb-458c-991d-f8bb6929c172"><h2>Bellvitge Hospital and AstraZeneca pilot app for Congestive Heart Failure</h2>

docdok

<img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fdocdok.png?alt=media&amp;token=345f765b-304b-439e-b25f-0b430ad53349"><h2>AstraZeneca and docdok.health improving asthma control</h2>

SCALE

BeyondBio - SCALE

<h1 class="ql-align-center">AI</h1><h2 class="ql-align-center">BeyondBio</h2><h2 class="ql-align-center">Where AI Meets Pharma's R&amp;D</h2><img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fai-hero-logos.png?alt=media&amp;token=1a2b0e93-6b79-4780-9485-320067a36962" alt="logos of companeis">

<h2>TRANSFORMING R&amp;D WITH AI</h2> The AI revolution is well underway. Yet our industry has only scratched the surface of how it will transform the discovery and development of life-changing medicines. BeyondBio AI is working towards that future, creating an unparalleled space for innovation to thrive.From building new AI ventures to championing existing platforms, we connect Israel’s best solutions to pharma’s most pressing R&amp;D challenges. At the heart: matching bold entrepreneurs, scientists, and technologists with deep industry knowledge, scientific expertise, and data. The result? Fast-tracked progress that makes a crucial difference in startups’ success.&nbsp;

AION Labs

<h2>AION LABS TRACK</h2> In this pioneering lab, new Israeli startups are tailor-made to address pharma’s most urgent problems with precision. A key initiative of BeyondBio AI, AION Labs was born of a groundbreaking alliance of AstraZeneca, Merck, Pfizer, and Teva, along with AWS and the Israel Biotech Fund, supported by the Israeli Innovation Authority. If you’re a scientist, technologist or entrepreneur looking to establish your startup with deep support from across the industry, we welcome you to get in touch.

R&D Direct track

<h2>R&amp;D DIRECT TRACK</h2> This track is tailored to exciting, evidence-based AI platforms, selected for direct collaboration with AstraZeneca’s R&amp;D teams. Working together, we steer innovation with rare precision and speed: from matching a solution to a viable problem, to refining its value proposition, validation, and deployment through a range of collaboration models.&nbsp; We’re always looking for groundbreaking solutions. Get in touch if you have an AI platform geared at transforming the R&amp;D journey, from the early drug discovery phase up to clinical trial success. Let’s explore how we can work together to unlock your startup’s full potential.&nbsp;

BeyondBio - AI

<h1 class="ql-align-center">DATA</h1><h2 class="ql-align-center">BeyondBio</h2><h2 class="ql-align-center">Israel's Natural Resource</h2>

<h2>THE NEXT FRONTIER IN DATA SCIENCE</h2> The AI revolution is poised to transform healthcare as we know it – and data is the key. That’s at the core of our DATA hub in Israel: advancing the frontiers of data science and research to dramatically improve patient care on a global scale. Joining forces in that mission are partners from across the ecosystem, from academia, to healthcare providers, government initiatives, and startups leading the way in safe and efficient data accessibility.

A small nation

<h2>A SMALL NATION WITH BIG POTENTIAL</h2> Our home base is Israel, a small country with enormous potential to advance the global understanding of disease. A leader in the early adoption of medical technology, Israel also stands to be a first-of-its-kind source of medical insight. That’s thanks to an advanced, centralized health care system and a wealth of digitized, longitudinal medical data.

Ready to talk

<h2>READY TO TALK DATA?</h2> Together we can unlock the value of data, while safeguarding privacy and making life-changing leaps in patient care, from preventative treatments to better diagnoses, disease management, precision medicine and drug discovery and development. If you are a data-driven innovator interested in joining this collaboration, we welcome you to reach out.

DATA

BeyondBio - DATA

<h1 class="ql-align-center">RESEARCH</h1><h2 class="ql-align-center">BeyondBio</h2><h2 class="ql-align-center">Seeding Exceptional Collaboration in Science<img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fresearch-hero-logos.png?alt=media&amp;token=8996d811-bd62-4925-bb10-c2154470a889" alt="company logos"></h2>

Harnessing

<h2>HARNESSING ISRAEL'S SCIENTIFIC COMMUNITY TOWARD NOVEL THERAPEUTICS</h2> In partnership with leading academic institutions and VCs, BeyondBio Research harnesses Israel’s exceptional scientific community to identify novel science and breakthrough technologies in pharmaceuticals. We connect Israel’s top scientists, talented entrepreneurs and key opinion leaders with experts form across AstraZeneca’s global R&amp;D. Through that deep collaboration, we’re focused on new therapeutics in the following areas: a. Cardiovascular, Renal and Metabolic disease&nbsp;b. Respiratory and Immunologyc. Oncologyd. Rare diseasese. Vaccines and Infectious diseasesf. Enabling technologies Do you think your novel science or technology may be of interest to AstraZeneca?We welcome you to reach out.

Learn more

CARDIOVASCULAR, RENAL & METABOLIC DISEASE

Our bold ambition is to stop, reverse, and cure CVRM diseases by maximizing our medicines, delivering innovative solutions, and advancing our pipeline. The impacts of CVRM diseases on people, society and our planet are immense and growing, yet they remain underdiagnosed, undertreated and their interconnections under-recognized. These conditions affect hundreds of millions of people around the world; we estimate that one in three people with a CVRM disease are living with two or more of these chronic diseases. Our ambition is to enhance care to improve outcomes for the millions of people who are living with the complexities of CVRM diseases, to intervene early to protect vital organs, slow or stop disease progression, and one day even cure these often debilitating, progressive and life-threatening conditions. Through understanding the interconnections of these conditions, we’re able to extend the use of our existing medicines and build one of the world’s broadest, deepest and strongest CVRM pipelines. 9 By 2032, we aim to be leading the world in CVRM therapies, helping to change the course and reach of medical practice. <a href="https://www.astrazeneca.com/our-therapy-areas/cardiovascular-renal-and-metabolism.html" rel="noopener noreferrer" target="_blank">Read more</a>

RASPIRATORY & IMMUNOLOGY

We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. Our portfolio of inhaled and biologic medicines, and our pipeline for the future, seek to address the challenges and vast unmet medical needs patients face today. With five decades of experience, we are an established leader in respiratory care and a disruptor in immunology. We are committed to transforming care for some of the most debilitating and chronic respiratory and immune-mediated diseases. Our portfolio of inhaled and biologic medicines, and our pipeline for the future, seek to address the challenges and vast unmet medical needs patients face today. By following the science, we are focused on sustainably addressing tough and complex unsolved problems. Our approach involves targeting the underlying biology, developing effective new drug modalities and combinations and applying a precision medicine approach from the start of discovering medicines, all while driving earlier detection, diagnosis and intervention. <a href="https://www.astrazeneca.com/our-therapy-areas/respiratory-and-immunology.html" rel="noopener noreferrer" target="_blank">Read more</a>

ONCOLOGY

We have a bold&nbsp;ambition to&nbsp;provide cures for cancer in&nbsp;every form. We are following the science to&nbsp;understand cancer and&nbsp;all&nbsp;its complexities&nbsp;to discover, develop and deliver life-changing treatments and increase the potential to save the lives of people around the world. Our Oncology strategy is built with one goal in mind – to push the boundaries of science to change the practice of medicine and transform the lives of patients living with cancer. Our broad pipeline of next-generation medicines, together with our focus on excellence in execution, are aimed at expanding treatment options and improving outcomes for patients with solid tumours and haematological cancers.&nbsp; <a href="https://www.astrazeneca.com/our-therapy-areas/oncology.html" rel="noopener noreferrer" target="_blank">Read more</a>

VACCINES & INFECTIOUS DISEASES

Our ambition is to develop and deliver transformative vaccines and antibodies, providing long-lasting immunity for millions of people, where the burden of disease is greatest.&nbsp; We are committed to developing and delivering transformative vaccines and antibodies, providing long lasting immunity for millions of people, where the burden of disease is greatest. During the COVID-19 pandemic, we played an important role as part of a truly global effort to respond to a new and unprecedented challenge.1&nbsp;We will continue to advance science in vaccines and immune therapies and work with partners to drive improvements in public health and ensure our science reaches millions more people. <a href="https://www.astrazeneca.com/our-therapy-areas/vaccines-and-immune-therapies.html" rel="noopener noreferrer" target="_blank">Read More</a>

ENABLING TECHNOLOGIES

We’re interested in cutting-edge technologies to enhance the quality, effectiveness, and productivity of our research and translational capabilities, including:&nbsp; <ul><li>Target validation tools and technologies</li><li>Novel HTS/lead generation approaches</li><li>Novel chemical libraries with evidence of biological relevance</li><li>Predictive safety and predictive efficacy platforms</li><li>Drug delivery platforms and medical device technologies</li><li>Novel delivery, manufacturing and analytical processes</li><li>New systems for drug targeting</li><li>Stem cell biology</li><li>Novel technologies for antibodies and vaccines</li><li>Application of artificial intelligence and machine learning to drug discovery and development</li><li>Point-of-care testing</li><li>Monitoring devices</li><li>CRISPR</li></ul>

RARE DISEASES

The work we do is guided by people living with rare and devastating diseases. We are driven to continuously innovate and create meaningful value in all we do to help patients and families fully live their best lives. <a href="https://alexion.com/our-research/research-partnerships" rel="noopener noreferrer" target="_blank">Read more</a>

RESEARCH

BeyondBio - RESEARCH

News

﻿in

May 19, 2023

May 19, 2023<h2>AstraZeneca launches pilot program for Cordio Medical’s AI heart failure appneca launches pilot program for Cordio Medical’s AI heart failure app</h2>

Feb 28,2023

Feb 28, 2023<h2>New Israeli company aims to design life-saving proteins from scratch</h2>

Jan 24, 2023

Jan 24, 2023<h2>Ibex Medical Analytics enters collaboration with AstraZeneca and Daiichi Sankyo to develop AI-based HER2 scoring product</h2>

Jan 05, 2023

Jan 05, 2023<h2>C2i Genomics announces successful evaluation of whole genome-based residual disease test across multiple solid cancer models</h2>

Dec 18, 2022

Dec 18, 2022<h2>Six Israeli startups selected to participate in BeyondBio SCALE program</h2>

Jul 5, 2022

Jul 5, 2022<h2>AstraZeneca enters into cooperation with Swiss-Israeli startup docdok.health to improve the treatment of respiratory diseases</h2>

Sep28, 2022

Sep28, 2022&nbsp;<h2>Pfizer, AstraZeneca, Merck KGaA-backed Israeli AI incubator launches first biopharma startup</h2>

Oct 13, 2021

Oct 13, 2021<h2>An Israeli lab tests a unique way of collaborating and scaling AI</h2>

Press

פריים חדש 1

פריים חדש 2

בדיקות תוכנה

Opening Titles

UNLEASHING

<h2>UNLEASHING OUR POTENTIAL</h2> Bold innovation and scientific breakthroughs in global health are within our reach – but they require a completely new model of collaboration and problem solving. On their own, startups run into countless obstacles that too often prevent great ideas from turning into life-changing technologies. BeyondBio is reimagining that. Through four key pathways - Scale, AI, Data, and Research - startups are given unparalleled access to industry expertise, vast scientific insight, data, and more, across the health care ecosystem. Collective wisdom that empowers innovators to push the boundaries of science.&nbsp;

MEETING OF MINDS

<h2>MEETING OF MINDS</h2> Scientists, entrepreneurs, health care providers, tech companies and our pharma peers each hold vital pieces of the puzzle. Together, we can transform patient life as we know it, from R&amp;D, to preventative medicine, better diagnostics and personalized treatments. BeyondBio is proud to be part of A.Catalyst, a global network of AstraZeneca innovation hubs sharing that vision. With deep partnerships that cross borders and barriers, we can tailor precise solutions to the biggest healthcare challenges of today and tomorrow. When that happens, everybody wins – first and foremost, patients.

CLEARING THE PATH

<h2>CLEARING THE PATH FOR INNOVATION</h2> Israel’s government plays a key role in setting the stage for innovation, clearing the path for startups to flourish, and providing support for new technologies. Working together, we help ensure startups have fewer barriers and more tools to succeed, from conception to deployment.

Pathways

Scale

BeyondBio<h3>SCALE</h3>For mature startups ready to scale up&nbsp; <img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fpathway1.png?alt=media&amp;token=193b6f15-d5d0-4ed1-b825-b43ffa024d7a">

BeyondBio<h3>AI</h3>For AI entrepreneurs, startups and scientists <img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fpathway3.png?alt=media&amp;token=d832e270-07a2-4638-a9c5-a4a4d56b1a2e">

Data

BeyondBio<h3>DATA</h3>For data-driven ecosystem innovators&nbsp; <img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fpathway2.png?alt=media&amp;token=8ae60cc2-59ab-41b7-b78d-4c4e2837b380">

Reasearch

BeyondBio<h3>RESEARCH</h3>For startups and academic innovators&nbsp; <img src="https://firebasestorage.googleapis.com/v0/b/delta-shop-1d306.appspot.com/o/0tex5S38jsQbHXBHemvvLmj7q333%2Fpathway4.png?alt=media&amp;token=45f84862-d7dc-4740-815b-66126a93816e">

Home

SCALE

AI

DATA

RESEARCH

Press

THE NEXT FRONTIER IN DATA SCIENCE

A SMALL NATION WITH BIG POTENTIAL

READY TO TALK DATA?

BeyondBio by AstraZeneca